MCID: CRN027
MIFTS: 42

Corneal Neovascularization malady

Category: Eye diseases

Aliases & Classifications for Corneal Neovascularization

About this section

Aliases & Descriptions for Corneal Neovascularization:

Name: Corneal Neovascularization 10 47 12 36 65

Classifications:



External Ids:

Disease Ontology10 DOID:11382
ICD1027 H16.4, H16.40
ICD9CM29 370.6, 370.60
MeSH36 D016510
UMLS65 C0085109

Summaries for Corneal Neovascularization

About this section
Wikipedia:68 Corneal neovascularization is the excessive ingrowth of blood vessels from the limbal vascular plexus... more...

MalaCards based summary: Corneal Neovascularization is related to rheumatoid arthritis and breast cancer. An important gene associated with Corneal Neovascularization is VEGFA (Vascular Endothelial Growth Factor A), and among its related pathways are Integrins in angiogenesis and Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include eye, endothelial and testes, and related mouse phenotypes are tumorigenesis and digestive/alimentary.

Related Diseases for Corneal Neovascularization

About this section

Diseases related to Corneal Neovascularization via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 299)
idRelated DiseaseScoreTop Affiliating Genes
1rheumatoid arthritis29.2CXCL12, FLT1, TEK, VEGFA
2breast cancer28.5CXCL12, FGF2, FLT1, KDR, ROBO1, TEK
3myocardial infarction27.8CXCL12, FGF2, FLT1, HRG, KDR, PLG
4warty dyskeratoma10.4FGF2, VEGFA
5right bundle branch block10.4FLT1, VEGFA
6residual stage angle-closure glaucoma10.4FGF2, VEGFA
7clivus chondroid chordoma10.4CXCL12, FGF2
8endotheliitis10.4
9suprasellar meningioma10.3SERPINF1, VEGFA
10grayson-wilbrandt corneal dystrophy10.3FGF2, VEGFA
11hepatitis10.3
12meningocele10.3KDR, VEGFA
13protein s deficiency10.3SERPINF1, VEGFA
14refractory plasma cell neoplasm10.3PLG, VEGFA
15gastric neuroendocrine neoplasm10.3KDR, VEGFA
16uterine corpus myxoid leiomyosarcoma10.3THBS1, VEGFA
17eccrine sweat gland neoplasm10.3PLG, VEGFA
18childhood kidney cell carcinoma10.3CXCL12, SERPINF1, VEGFA
19adenosarcoma of the uterus10.2TIMP2, VEGFA
20pleomorphic adenoma carcinoma10.2CXCL12, KDR
21hemangioblastoma10.2CXCL12, VEGFA
22large intestine adenocarcinoma10.2FGF2, VEGFA
23glycerol kinase deficiency, adult form10.2FGF2, PLG, VEGFA
24conduct disorder10.2KDR, SERPINF1, VEGFA
25leukemia10.2
26lymphoma10.2
27prostatitis10.2
28congenital methemoglobinemia10.2FGF2, TIMP2
29inherited metabolic disorder10.2FGF2, KDR, VEGFA
30bladder urachal squamous cell carcinoma10.2FLT1, KDR, VEGFA
31dyskinesia of esophagus10.2SERPINF1, VEGFA
32immature cataract10.2FLT1, KDR, VEGFA
33chronic venous insufficiency10.2FGF2, KDR, VEGFA
34hypospadias-hypertelorism-coloboma and deafness syndrome10.1FLT1, KDR, VEGFA
35seminal vesicle acute gonorrhea10.1FLT1, KDR, VEGFA
36adult pulmonary langerhans cell histiocytosis10.1FLT1, KDR, VEGFA
37hiv-110.1
38arthritis10.1
39ovarian cancer10.1
40cervicitis10.1
41cerebritis10.1
42tuberculosis10.1
43neuropathy10.1
44intracranial hemorrhage in brain cerebrovascular malformations10.1FGF2, KDR, VEGFA
45common bile duct neoplasm10.1FLT1, TIMP2, VEGFA
46breast metaplastic carcinoma10.1PLG, TEK
47pheochromocytoma10.0
48colorectal cancer10.0
49systemic lupus erythematosus10.0
50malaria10.0

Graphical network of the top 20 diseases related to Corneal Neovascularization:



Diseases related to corneal neovascularization

Symptoms for Corneal Neovascularization

About this section

Drugs & Therapeutics for Corneal Neovascularization

About this section

Drugs for Corneal Neovascularization (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 75)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bevacizumabapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 11875216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
2
RanibizumabapprovedPhase 4, Phase 1460347396-82-1459903
Synonyms:
347396-82-1
D05697
Lucentis
Lucentis (TN)
 
Ranibizumab
Ranibizumab (USAN/INN)
Ranibizumab (genetical recombination)
Ranibizumab (genetical recombination) (JAN)
ranibizumab
rhuFab V2
3Immunologic FactorsPhase 4, Phase 118483
4Angiogenesis InhibitorsPhase 4, Phase 2, Phase 3, Phase 13688
5Pharmaceutical SolutionsPhase 4, Phase 3, Phase 1, Phase 27004
6Angiogenesis Modulating AgentsPhase 4, Phase 2, Phase 3, Phase 13611
7AnestheticsPhase 4, Phase 27385
8AntibodiesPhase 4, Phase 2, Phase 14477
9ImmunoglobulinsPhase 4, Phase 2, Phase 14477
10Antibodies, MonoclonalPhase 4, Phase 22413
11
TriamcinoloneapprovedPhase 2, Phase 3448124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11beta,16alpha,17alpha,21-Tetrahydroxy-9alpha-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Allernaze
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
MLS000028542
MLS001066543
 
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone Acetonide
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Trianex
Triatex
Tricortale
Triderm
Triesence
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
12
Voriconazoleapproved, investigationalPhase 3124137234-62-971616
Synonyms:
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,S*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(R-(R*,s*))-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-Difluorophenyl)-5-fluoro-beta-methyl-alpha-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
(alphaR,betaS)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol
137234-62-9
173967-54-9
AC-823
AC1L2GHR
AC1Q4O6I
AKOS005145705
C07622
C102790
CHEBI:10023
CHEMBL638
CID71616
CPD000466350
D00578
DB00582
DRG-0301
FT-0082604
HMS2051N09
LS-181799
 
MLS000759464
MLS001424082
MolPort-003-850-863
Pfizer brand of voriconazole
S1442_Selleck
SAM001246664
SMR000466350
TL8000858
UK 109,496
UK 109496
UK-109,496
UK-109496
UNII-JFU09I87TR
VCZ
VRC
Vfend
Vfend (TN)
Vfend, Voriconazole
Voriconazol
Voriconazole
Voriconazole (JAN/USAN/INN)
Voriconazole [USAN:INN:BAN]
Voriconazole in combination with MGCD290
Voriconazolum
ZINC00014864
voriconazole
13
Miconazoleapproved, investigationalPhase 3302622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
14
NatamycinapprovedPhase 377681-93-85281099
Synonyms:
(1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.0~5,7~]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure
6,11,28-Trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid, 22-[(3-amino-3,6-dideoxy-.beta.-D-mannopyranosyl)oxy]-1,3,26-trihydroxy-12-methyl-10-oxo-, (1R,3S,5R,7R,8E,12R,14
7681-93-8
80482_FLUKA
A 5283
AC-15226
AC1LCW93
AC1MC3GI
Antibiotic A 5283
Antibiotic A-5283
C08073
C33H47NO13
CHEMBL1200656
CID657250
CL 12,625
CL 12625
CL-12625
CPD000466358
D00884
DB00826
Delvocid
Delvolan
Delvopos
E235
EINECS 231-683-5
HMS1571M10
LS-7662
MLS000069611
MLS000759475
MolPort-003-939-127
MolPort-005-935-314
Mycophyt
Myprozine
 
NATAMYCIN
Natacyn
Natacyn (TN)
Natafucin
Natamicina
Natamicina [INN-Spanish]
Natamycin
Natamycin (USP/INN)
Natamycin [USAN:INN:BAN]
Natamycin preparation
Natamycine
Natamycine [INN-French]
Natamycinum
Natamycinum [INN-Latin]
P0440_SIGMA
P9703_SIGMA
PMR
Pimafucin
Pimafugin
Pimaricin
Pimaricin (JP15)
Pimaricin preparation
Pimaricine
Pimarizin
Pimarizin [German]
Prestwick2_001104
SAM001246683
SMP1_000240
SMR000058788
SMR000466358
Stereoisomer of 22-((3-amino-3,6-dideoxy-beta-D-mannopyranosyl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo(22.3.1.0(sup 5,7))octacosa-8,14,16,18,20-pentaene-25-carboxylic acid
Synogil
Tennecetin
Tymasil
UNII-8O0C852CPO
pimaricin
15
OxytetracyclineapprovedPhase 2, Phase 3879-57-25280972
Synonyms:
(2E,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2E,4S,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6S,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,6,10,11,12a-pentahydroxy-6-methyl-4,4a,5,5a-tetrahydrotetracene-1,3,12-trione
(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
102287-29-6
103351-03-7
105145-10-6
106216-57-3
1405-95-4
15251-48-6
2058-46-0 (Mono-hydrochloride)
2058-46-0 (mono-hydrochloride)
21645-09-0
4-14-00-02633 (Beilstein Handbook Reference)
5-Hydroxy-Tetracycline
5-Hydroxytetracycline
52214-46-7
6153-64-6 (Di-hydrate)
6153-64-6 (di-hydrate)
6153-65-7 (Di-hydrochloride salt, di-hydrate)
6153-65-7 (di-hydrochloride salt, di-hydrate)
64038-91-1 (sulfate (2:1))
69766-62-7 (hydrochloride salt)
7179-50-2 (Calcium (1:1) salt)
7179-50-2 (calcium (1:1) salt)
79-57-2
79-57-2 (ANHYDROUS)
856305-69-6
96310-42-8
AC-12777
AC1NQXTY
AC1NQZMP
AC1NS4NE
AC1O52HP
AKOS001632631
Abbocin
Adamycin
Antibiotic TM 25
BPBio1_000302
BRN 2714587
BSPBio_000274
BSPBio_002151
Berkmycen
Biostat
Biostat PA
Biostat pa
Bisolvomycin
C06624
C22H24N2O9
CHEBI:27701
CHEMBL1517
CID5280972
CID5282186
CID5353856
CID6426716
DB00595
Dabicycline
Dalimycin
DivK1c_000225
EINECS 201-212-8
Embryostat
Fanterrin
Galsenomycin
Geomycin
Geomycin (Streptomyces vimosus)
Geotilin
HSDB 3145
Hydroxytetracycline
Hydroxytetracyclinum
IDI1_000225
Imperacin
KBio1_000225
KBio2_001535
KBio2_004103
KBio2_006671
KBio3_001651
KBioGR_000912
KBioSS_001535
LA 200
LMPK07000005
LS-93860
Lenocycline
Liquamycin
Liquamycin LA 200
 
MLS000069429
Macocyn
Medamycin
Mepatar
MolPort-002-524-946
MolPort-005-934-326
Mycoshield TMQTHC 20
NCGC00091268-04
NCGC00091268-05
NCI-C56473
NINDS_000225
NSC 9169
NSC-9169
NSC9169 (HCL)
OTC
OTC (antibiotic)
Oksisyklin
Ossitetraciclina
Ossitetraciclina [DCIT]
Oxacycline
Oxitetraciclina
Oxitetraciclina [INN-Spanish]
Oxitetracyclin
Oxitetracycline
Oxitetracyclinum
Oxy-kesso-tetra
Oxydon
Oxymycin
Oxymykoin
Oxypam
Oxysteclin
Oxyterracin
Oxyterracine
Oxyterracyne
Oxytetracid
Oxytetracyclin
Oxytetracycline (anhydrous)
Oxytetracycline (internal use)
Oxytetracycline HCl
Oxytetracycline Hydrochloride
Oxytetracycline [INN]
Oxytetracycline [inn]
Oxytetracycline amphoteric
Oxytetracycline anhydrous
Oxytetracycline calcium
Oxytetracyclinum
Oxytetracyclinum [INN-Latin]
Oxytétracycline
Pennox 200
Prestwick0_000307
Prestwick1_000307
Prestwick2_000307
Prestwick3_000307
Proteroxyna
Riomitsin
Ryomycin
S1773_Selleck
SMR000059000
SPBio_001055
SPBio_002493
STOCK1N-50853
Solkaciclina
Spectrum2_000988
Spectrum3_000536
Spectrum4_000466
Spectrum5_001148
Spectrum_001055
Stecsolin
Stevacin
TM 5
Tarocyn
Tarosin
Teravit
Terrafungine
Terramitsin
Terramycin
Terramycin Q50
Terramycin im
Terramycin, Liquamycin, Oxytetracycline
Tetran
UNII-SLF0D9077S
UNII-X20I9EN955
Unimycin
Ursocyclin
Ursocycline
Vendarcin
oxytetracycline
16
Doxycyclineapproved, investigationalPhase 2, Phase 3219564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
17MitogensPhase 2, Phase 31386
18Endothelial Growth FactorsPhase 2, Phase 3328
19triamcinolone acetonidePhase 2, Phase 3448
20Triamcinolone diacetatePhase 2, Phase 3448
21Anti-Bacterial AgentsPhase 3, Phase 2, Phase 19140
22Triamcinolone hexacetonidePhase 2, Phase 3448
23Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 39988
24Anti-Infective AgentsPhase 3, Phase 217220
25Anti-Infective Agents, LocalPhase 3984
26HormonesPhase 311748
27Antifungal AgentsPhase 33015
28Cytochrome P-450 CYP3A InhibitorsPhase 31421
29Hormone AntagonistsPhase 310002
30Cytochrome P-450 Enzyme InhibitorsPhase 33036
31Contraceptives, OralPhase 2, Phase 33734
32Antiprotozoal AgentsPhase 2, Phase 31730
33Antiparasitic AgentsPhase 2, Phase 31854
34AntimalarialsPhase 2, Phase 31058
35CatharticsPhase 1, Phase 2344
36LaxativesPhase 1, Phase 2344
37Carboxymethylcellulose SodiumPhase 1, Phase 2105
38Gastrointestinal AgentsPhase 1, Phase 26401
39TetrahydrozolinePhase 1, Phase 2542
40Ophthalmic SolutionsPhase 1, Phase 21006
41Antirheumatic AgentsPhase 1, Phase 28496
42Interleukin 1 Receptor Antagonist ProteinPhase 1, Phase 235
43
PseudoephedrineapprovedPhase 144790-82-47028
Synonyms:
( )-Pseudoephedrine
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-Psi-ephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-2-methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D-Psi-ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephed 60
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-Psi-ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine Hydrochloride
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrine hydrochloride
Pseudoephedrine sulfate
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Suphedrine
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
trans-Ephedrine
44
EphedrineapprovedPhase 1447299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
45
ZincapprovedPhase 114777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
46
BetamethasoneapprovedPhase 1153378-44-99782
Synonyms:
.beta.-Methasone
.beta.-Methasone alcohol
1,4-Pregnadiene-3,20-dione-9alpha-fluoro-16 beta-methyl-11 beta,17alpha,21-triol
16beta-Methyl-1,4-pregnadiene-9alpha-fluoro-11beta,17alpha,21-triol-3,20-dione
16β-Methyl-1,4-pregnadiene-9α-fluoro-11β,17α,21-triol-3,20-dione
24024-03-1
34166_FLUKA
34166_RIEDEL
378-44-9
4-08-00-03501 (Beilstein Handbook Reference)
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione
9-Fluoro-16.beta.-methylprednisolone
9-Fluoro-16beta-methylprednisolone
9-Fluoro-16β-methylprednisolone
9-alpha-Fluoro-16-beta-methylprednisolone
9.alpha.-Fluoro-16.beta.-methylprednisolone
9alpha-Fluoro-16 beta-methyl-prednisolone
9alpha-Fluoro-16beta-methylprednisolone
9α-Fluoro-16β-methylprednisolone
AC1L1EYE
AC1L1TT4
AC1Q5HJZ
AKOS001582690
AR-1A7284
AR-1H5595
B1837
B7005_SIAL
B7005_SIGMA
B9675_SIAL
BIDD:PXR0047
BPBio1_000533
BRD-A35108200-001-04-7
BRD-K39188321-001-03-9
BRN 3176546
BSPBio_000483
Bebate
Becort
Bedifos
Betacorlan
Betacortril
Betadexamethasone
Betafluorene
Betamamallet
Betametasona
Betametasona [INN-Spanish]
Betametasone
Betametasone [DCIT]
Betamethasone
Betamethasone (JP15/USP/INN)
Betamethasone Base
Betamethasone Dipropionate
Betamethasone Valearate
Betamethasone Valerate
Betamethasone [USAN:BAN:INN:JAN]
Betamethasone [USAN:INN:BAN:JAN]
Betamethasone alcohol
Betamethasone cream
Betamethasone dipropionate
Betamethasone sodium phosphate
Betamethasone valerate
Betamethasonum
Betamethasonum [INN-Latin]
Betamethasonvalerat Mikron
Betamethazone
Betapredol
 
Betasolon
Betnelan
Betsolan
C22H29FO5
CHEBI:3077
CHEMBL632
CID3003
CID9782
CPD000339803
Celestene
Celeston
Celestona
Celestone
Celestone Syrup and Tablets
Celestone, Betadexamethasone, Flubenisolone, Sch-4831, NCS-39470, Betamethasone
Cellestoderm
Cidoten
D00244
D1961
DB00443
Desacort-Beta
Diprolene
EINECS 206-825-4
Flubenisolone
HMS1569I05
HSDB 3015
Hormezon
I06-0121
KST-1A3042
LS-118466
LT00441022
Luxiq
Luxiqo
MLS-0310139.0001
MLS000686794
MLS000859943
MLS001066413
MLS001332616
MLS002153244
Methazon
MolPort-003-845-025
MolPort-007-981-051
NCGC00164401-01
NCGC00164401-02
NSC 39470
NSC-39470
NSC39470
Prestwick0_000362
Prestwick1_000362
Prestwick2_000362
Prestwick3_000362
Prestwick_703
Rinderon
Rinderon (TN)
Rinderon A
S1500_Selleck
SAM002589959
SCH 4831
SCH-4831
SMP1_000043
SMR000058601
SMR000339803
SPBio_002404
UNII-9842X06Q6M
Valisone
Visubeta
ZINC03876136
beta-Methasone
beta-Methasone alcohol
betamethasone
47
TropicamideapprovedPhase 1211508-75-45593
Synonyms:
(+-)-N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
1508-75-4
5-22-09-00359 (Beilstein Handbook Reference)
AB00052120
AC-816
AC1L1KOZ
AC1Q5IFA
AR-1K6980
Akorn Brand of Tropicamide
Alcon Brand of Tropicamide
BPBio1_000303
BRD-A79672927-001-05-8
BRN 0285563
BSPBio_000275
BSPBio_002289
Bio-0810
Bistropamide
Bournonville Brand of Tropicamide
CHEMBL1200604
CID5593
CPD000058523
Cahill May Roberts Brand of Tropicamide
Chauvin Brand of Tropicamide
Colircusi Tropicamida
D00397
D014331
DB00809
DivK1c_000448
EINECS 216-140-2
EU-0101223
Epitromina
HMS1568N17
HMS1921I09
HMS2089M05
HMS2092A18
HMS501G10
I-Picamide
I06-0811
IDI1_000448
KBio1_000448
KBio2_001064
KBio2_003632
KBio2_006200
KBio3_001509
KBioGR_000873
KBioSS_001064
L001262
LS-28545
Lopac0_001223
MLS001306442
MLS002154240
Medical Ophthalmics Brand of Tropicamide
Minims tropicamide
MolPort-000-159-321
Mydral
Mydriacyl
Mydriacyl (TN)
Mydriafair
Mydriaticum
Mydrum
N-Ethyl-2-phenyl-N-(4-pyridylmethyl)hydracrylamide
N-Ethyl-2-phenyl-N-4-[-pyridyl-methyl]hydracrylamide
N-Ethyl-N-(4-pyridylmethyl)tropamid
N-Ethyl-N-(4-pyridylmethyl)tropamide
N-Ethyl-alpha-(hydroxymethyl)-N-(4-pyridinylmethyl)benzeneacetamide
N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide
NCGC00016065-03
NCGC00016065-08
 
NCGC00024866-02
NCGC00024866-03
NCGC00024866-04
NCGC00024866-05
NCGC00024866-06
NINDS_000448
Novartis Brand of Tropicamide
Ocu Tropic
Ocu-Tropic
OcuTropic
Ocumed Brand of Tropicamide
Ocusoft Brand of Tropicamide
Opticyl
Paremyd
Pharmafair Brand of Tropicamide
Prestwick0_000228
Prestwick1_000228
Prestwick2_000228
Prestwick3_000228
Prestwick_487
Rivex Brand of Tropicamide
Ro 1-7683
SAM002564235
SMP1_000304
SMR000058523
SPBio_000872
SPBio_002196
SPECTRUM1500599
STK934612
Spectro-Cyl
Spectrum2_000936
Spectrum3_000655
Spectrum4_000377
Spectrum5_001585
Spectrum_000584
Stulln Brand 1 of Tropicamide
Stulln Brand 2 of Tropicamide
T 9778
T9778_SIGMA
TL8001101
Triaminic DM
Tropicacyl
Tropicamid
Tropicamida
Tropicamida [INN-Spanish]
Tropicamide
Tropicamide (JP15/USP/INN)
Tropicamide Alcon Brand
Tropicamide Chauvin Brand
Tropicamide Faure
Tropicamide Minims
Tropicamide Monofree
Tropicamide Monohydrochloride, (R)-Isomer
Tropicamide Monohydrochloride, (S)-Isomer
Tropicamide Novartis Brand
Tropicamide Ocumed Brand
Tropicamide Pharmafair Brand
Tropicamide Rivex Brand
Tropicamide [USAN:INN:BANJAN]
Tropicamide, (+-)-Isomer
Tropicamide, (R)-Isomer
Tropicamide, (S)-Isomer
Tropicamidum
Tropicamidum [INN-Latin]
Tropikamid
Tropimil
UNII-N0A3Z5XTC6
Visumidriatic
n-ethyl-n-(g-picolyl)tropamide
tropicamide
48Insulin, Globin ZincPhase 14278
49MydriaticsPhase 1525
50Respiratory System AgentsPhase 13931

Interventional clinical trials:

(show top 50)    (show all 51)
idNameStatusNCT IDPhase
1The Effect of Bevacizumab on Corneal NeovascularizationCompletedNCT00797303Phase 4
2Clinical Performance of Biofinity Toric Versus Air Optix for AstigmatismCompletedNCT01965288Phase 4
3Efficacy and Safety of Autologous Cultivated Limbal Stem Cells Transplantation (ACLSCT) for Restoration of Corneal Epithelium in Patients With Limbal Stem Cell DeficiencyRecruitingNCT02577861Phase 4
4Strategies for Management of Corneal NeovascularisationNot yet recruitingNCT02594423Phase 4
5Evaluation of Changes in the Parameters of Optical Coherence Tomography After Intravitreal Injection of LucentisNot yet recruitingNCT01669447Phase 4
6Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal NeovascularizationCompletedNCT00555594Phase 2, Phase 3
7The Role of Amniotic Membrane Transplantation in Ocular Chemical BurnsRecruitingNCT00370812Phase 2, Phase 3
8Efficacy and Safety Study of Avastin to Treat Neovascularisation of the CorneaRecruitingNCT01501760Phase 3
9Mycotic Antimicrobial Localized Injection for Treatment of Corneal UlcersActive, not recruitingNCT02731638Phase 3
10Low Dose Doxycycline in the Treatment of Corneal BurnNot yet recruitingNCT01886560Phase 2, Phase 3
11Treatment of Corneal Neovascularization With Topical PazopanibCompletedNCT01257750Phase 1, Phase 2
12Topical IL-1-Ra for Treatment of Corneal NeovascularizationCompletedNCT00915590Phase 1, Phase 2
13Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalCompletedNCT01072357Phase 1, Phase 2
14Amniotic Membrane Graft In Syntomathic Bullous KeratopathyCompletedNCT01926535Phase 2
15Regenerative Medicine in Ocular Surface: Application of Cell Therapy for Ocular Surface Repair Using Progenitor Cells of Sclerocorneal Limbus Amplified ex VivoCompletedNCT01470573Phase 2
16Autologous Transplantation of Cultivated Limbal Stem Cells on Amniotic Membrane in Limbal Stem Cell Deficiency (LSD) PatientsCompletedNCT00736307Phase 1, Phase 2
17Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot StudyRecruitingNCT01843101Phase 2
18A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalRecruitingNCT01996826Phase 1, Phase 2
19Treatment of Hereditary Hemorrhagic Telangiectasia of the Nasal Mucosa by Intranasal Bevacizumab : Search for Effective DoseRecruitingNCT02157987Phase 1, Phase 2
20Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell DeficiencyRecruitingNCT01756365Phase 1, Phase 2
21Bevacizumab for the Treatment of Corneal NeovascularizationActive, not recruitingNCT00992849Phase 2
22Cultivated Autologous Oral Mucosal Epithelial Transplantation for the Treatment of Ocular Surface DiseasesActive, not recruitingNCT02739113Phase 1, Phase 2
23Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell DeficiencyActive, not recruitingNCT00845117Phase 1, Phase 2
24Limbal Epithelial Stem Cell Transplantation: a Phase II Multicenter TrialNot yet recruitingNCT02318485Phase 2
25Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar KeratoplastyNot yet recruitingNCT02424006Phase 1, Phase 2
26Transplantation of Cultivated Limbal Epithelium on Amniotic Membrane for Limbal Stem Cell DeficiencySuspendedNCT00348114Phase 2
27Topical Avastin for Treatment of Corneal NeovascularizationCompletedNCT00559936Phase 1
28Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)CompletedNCT00681889Phase 1
29Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant SurgeryCompletedNCT00769145Phase 1
30Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01075347Phase 1
31Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesCompletedNCT01031888Phase 1
32Ranibizumab for the Inhibition of Neovascularization in PterygiaCompletedNCT00768963Phase 1
33The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)CompletedNCT02649621Phase 1
34Bevacizumab Injection for Recurrent PterygiumCompletedNCT02007174Phase 1
35Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory ConditionsRecruitingNCT02042027Phase 1
36Using Aflibercept Injection to Treat Blood Vessel Growth Over the CorneaTerminatedNCT01868360Phase 1
37Evaluation of Biosynthetic Constructs to Replace Donor CorneasWithdrawnNCT02374723Phase 1
38Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal NeovascularizationCompletedNCT00512876
39Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal NeovascularizationCompletedNCT00004430
40Photodynamic Therapy With Verteporfin for Corneal NeovascularizationCompletedNCT00471406
41Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal NeovasculizationCompletedNCT00681603
42Vistakon Investigational Lens Worn as a Single Use Daily WearCompletedNCT01031004
43Assessment of Daily Disposable Silicone Hydrogel Lens WearCompletedNCT01093625
44Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to TrabeculectomyCompletedNCT01425112
45Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Silicone Hydrogel Soft Contact LensesCompletedNCT00382902
46Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic PatientsCompletedNCT00382603
47Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular DiseasesRecruitingNCT02448732Phase 0
48Daily Disposable Silicone Hydrogel Contact Lens, Stenfilcon A, Clinical StudyActive, not recruitingNCT02637804
49Neovascularization Patterns in Corneal Graft RejectionActive, not recruitingNCT01695655
50Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture MediaNot yet recruitingNCT00623584

Search NIH Clinical Center for Corneal Neovascularization


Cochrane evidence based reviews: corneal neovascularization

Genetic Tests for Corneal Neovascularization

About this section

Anatomical Context for Corneal Neovascularization

About this section

MalaCards organs/tissues related to Corneal Neovascularization:

33
Eye, Endothelial, Testes, Breast, Brain, Kidney, B cells

Animal Models for Corneal Neovascularization or affiliated genes

About this section

MGI Mouse Phenotypes related to Corneal Neovascularization:

38 (show all 12)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.8FGF2, PLG, ROBO1, THBS1, VEGFA
2MP:00053818.2PLG, ROBO1, SERPINF1, SLIT2, THBS1, VEGFA
3MP:00053918.1FGF2, FLT1, KDR, PLG, SERPINF1, TEK
4MP:00053897.8CXCL12, FGF2, FLT1, PLG, ROBO1, SERPINF1
5MP:00028737.7CXCL12, FLT1, KDR, ROBO1, TEK, TIMP2
6MP:00053697.3CXCL12, FGF2, FLT1, KDR, ROBO1, TEK
7MP:00053977.2CXCL12, FGF2, FLT1, KDR, PLG, TEK
8MP:00053847.2CXCL12, FGF2, FLT1, KDR, PLG, ROBO1
9MP:00053766.9FGF2, FLT1, KDR, PLG, ROBO1, TEK
10MP:00107686.4CXCL12, FGF2, FLT1, KDR, PLG, ROBO1
11MP:00036316.2CXCL12, FGF2, FLT1, KDR, PLG, ROBO1
12MP:00053855.8CXCL12, FGF2, FLT1, KDR, PLG, ROBO1

Publications for Corneal Neovascularization

About this section

Articles related to Corneal Neovascularization:

(show top 50)    (show all 380)
idTitleAuthorsYear
1
Polycystic horseshoe kidney. (26265824)
2015
2
Overexpression of Aurora-C interferes with the spindle checkpoint by promoting the degradation of Aurora-B. (24603334)
2014
3
Mutagenesis of hepatitis E virus helicase motifs: Effects on enzyme activity. (24333153)
2013
4
Telephone administration of the aberrant behavior checklist: a pilot study of feasibility in children with intellectual disability and autism. (24003069)
2013
5
Inherited secondary nephrogenic diabetes insipidus: concentrating on humans. (23364801)
2013
6
Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-consanguineous congenital forms in a Spanish population. (23922489)
2013
7
On call. I have read several news reports that claim finasteride, which I take for my prostate problem, can cause permanent impotence. Should I be concerned? (23807950)
2013
8
Leigh syndrome caused by a novel m.4296G>A mutation in mitochondrial tRNA isoleucine. (21982779)
2012
9
Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKI^ and IRS-1 pathways. (22766331)
2012
10
Bilateral visual loss due to a giant olfactory meningioma. (22419855)
2012
11
Endodontic management in a patient with vitamin D-resistant Rickets. (22244648)
2012
12
A prognostic model to identify patients with advanced pancreas adenocarcinoma who could benefit from second-line chemotherapy. (21382702)
2012
13
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. (21664161)
2011
14
Solution structure of the soluble receptor for advanced glycation end products (sRAGE). (21865159)
2011
15
A novel alanine or threonine 789 to proline mutation causing type 2N von Willebrand's disease when inherited homozygously or heterozygously with arginine 854 to glutamine mutation. (20491956)
2010
16
Longitudinal microvascularity in Achilles tendinopathy (power Doppler ultrasound, magnetic resonance imaging time-intensity curves and the Victorian Institute of Sport Assessment-Achilles questionnaire): a pilot study. (19711073)
2010
17
A role for PKD1 and PKD3 activation in modulation of calcium oscillations induced by orexin receptor 1 stimulation. (20621130)
2010
18
Postnatal in-vivo MRI findings in anencephaly. (21445817)
2010
19
A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency. (19231266)
2009
20
RACK1 associates with CLEC-2 and promotes its ubiquitin-proteasome degradation. (19785988)
2009
21
T-Wave morphology in short QT syndrome. (19614638)
2009
22
Socio-behavioral characteristics of children with Rubinstein-Taybi syndrome. (19350377)
2009
23
Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. (18990125)
2008
24
Cardiac autonomic dysfunction: effects from particulate air pollution and protection by dietary methyl nutrients and metabolic polymorphisms. (18378616)
2008
25
Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. (18925943)
2008
26
PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2. (18766263)
2008
27
A review on primary progressive aphasia. (19300609)
2007
28
Localized retinal ischemia as an ocular manifestation of primary antiphospholipid syndrome. (17508052)
2007
29
An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. (17259376)
2007
30
Activation of toll-like receptor 4 modulates vascular endothelial growth factor synthesis through prostacyclin-IP signaling. (17825254)
2007
31
Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. (16618833)
2006
32
Cytokine profiles during infliximab monotherapy in psoriatic arthritis. (16120138)
2005
33
Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage. (16365790)
2005
34
Lack of association of histamine-N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population. (16205835)
2005
35
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5. (15923218)
2005
36
Hepatopancreas gluconeogenesis during anoxia and post-anoxia recovery in Chasmagnathus granulata crabs maintained on high-protein or carbohydrate-rich diets. (14981783)
2004
37
Commonly recognised Plasmodium falciparum parasites cause cerebral malaria. (13680376)
2003
38
An opposing view on WWOX protein function as a tumor suppressor. (14695174)
2003
39
Nuclear IE2 structures are related to viral DNA replication sites during baculovirus infection. (11967334)
2002
40
Prenatal diagnosis of sacrococcygeal teratoma: a review of cases between 1993 and 2000. (12013082)
2002
41
Transcriptional regulation of expression of carbohydrate ligands for cell adhesion molecules in the selectin family. (14533803)
2001
42
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group. (11015339)
2000
43
Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors. (9865730)
1998
44
MUC1 peptide epitopes associated with five different H-2 class I molecules. (9368613)
1997
45
8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer. (9815703)
1997
46
Pemphigoid gestationis with autoantibodies exclusively directed to the 230-kDa bullous pemphigoid antigen (BP230Ag) (8731696)
1996
47
Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA-immortalized cervical epithelial cells. (7730415)
1995
48
Hormonal therapy for bleeding from angiodysplasia: chronic renal failure, et al?? (2252035)
1990
49
Observations upon the lymphopenia of x-ray irradiation. Part II. (14886582)
1951
50

Variations for Corneal Neovascularization

About this section

Expression for genes affiliated with Corneal Neovascularization

About this section
Search GEO for disease gene expression data for Corneal Neovascularization.

Pathways for genes affiliated with Corneal Neovascularization

About this section

Pathways related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 34)
idSuper pathwaysScoreTop Affiliating Genes
19.6FGF2, KDR, VEGFA
29.6FGF2, KDR, VEGFA
39.6FLT1, KDR, VEGFA
4
Show member pathways
9.6FLT1, KDR, VEGFA
5
Show member pathways
9.6FLT1, KDR, VEGFA
6
Show member pathways
9.6FLT1, KDR, VEGFA
79.6FLT1, KDR, VEGFA
8
Show member pathways
9.6FLT1, KDR, VEGFA
99.5HRG, PLG
109.4FLT1, TEK, VEGFA
11
Show member pathways
9.3FLT1, KDR, TEK
129.3FGF2, FLT1, KDR, VEGFA
13
Show member pathways
9.3FGF2, FLT1, KDR, VEGFA
14
Show member pathways
9.3FGF2, FLT1, KDR, VEGFA
159.3FGF2, KDR, PLG, VEGFA
169.2FGF2, KDR, THBS1, VEGFA
179.2FGF2, FLT1, SLIT2, VEGFA
189.1CXCL12, FGF2, PLG, THBS1
199.0CXCL12, FLT1, TEK, VEGFA
208.8CXCL12, ROBO1, SLIT2
218.8CXCL12, ROBO1, SLIT2
22
Show member pathways
8.6CXCL12, FGF2, FLT1, KDR, TIMP2
23
Show member pathways
8.6CXCL12, FGF2, FLT1, KDR, TIMP2
24
Show member pathways
8.6CXCL12, FGF2, FLT1, KDR, TIMP2
25
Show member pathways
8.6FGF2, KDR, PLG, THBS1, TIMP2
268.4FGF2, FLT1, KDR, TEK, THBS1, VEGFA
27
Show member pathways
8.4FGF2, FLT1, KDR, TEK, THBS1, VEGFA
288.3FGF2, FLT1, KDR, TEK, TIMP2, VEGFA
29
Show member pathways
8.1CXCL12, FGF2, FLT1, KDR, TEK, TIMP2
30
Show member pathways
8.1CXCL12, FGF2, FLT1, KDR, TEK, TIMP2
31
Show member pathways
8.1CXCL12, FGF2, FLT1, KDR, TEK, TIMP2
32
Show member pathways
7.9CXCL12, FGF2, FLT1, KDR, TEK, TIMP2
33
Show member pathways
7.9CXCL12, FGF2, FLT1, KDR, TEK, TIMP2
34
Show member pathways
7.8FGF2, KDR, ROBO1, SLIT2, TEK, VEGFA

GO Terms for genes affiliated with Corneal Neovascularization

About this section

Cellular components related to Corneal Neovascularization according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1proteinaceous extracellular matrixGO:00055789.8SLIT2, VEGFA

Biological processes related to Corneal Neovascularization according to GeneCards Suite gene sharing:

(show all 38)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.5KDR, VEGFA
2regulation of cGMP metabolic processGO:003082310.5THBS1, VEGFA
3positive regulation of endothelial cell migrationGO:001059510.5FGF2, THBS1
4positive regulation of cell divisionGO:005178110.5FGF2, VEGFA
5positive regulation of phospholipase C activityGO:001086310.5FGF2, FLT1
6positive chemotaxisGO:005091810.3FGF2, VEGFA
7cell migration involved in sprouting angiogenesisGO:000204210.3FGF2, KDR, VEGFA
8induction of positive chemotaxisGO:005093010.2CXCL12, VEGFA
9positive regulation of cell adhesionGO:004578510.2CXCL12, VEGFA
10vasculogenesisGO:000157010.2KDR, VEGFA
11negative regulation of lamellipodium assemblyGO:001059310.1HRG, SLIT2
12positive regulation of blood vessel endothelial cell migrationGO:004353610.1FGF2, THBS1, VEGFA
13negative regulation of endothelial cell apoptotic processGO:200035210.1KDR, TEK
14organ regenerationGO:003110010.1CXCL12, TEK
15negative regulation of endothelial cell chemotaxisGO:200102710.0HRG, THBS1
16fibrinolysisGO:004273010.0HRG, PLG
17chemorepulsion involved in postnatal olfactory bulb interneuron migrationGO:00218369.9ROBO1, SLIT2
18negative regulation of chemokine-mediated signaling pathwayGO:00701009.8ROBO1, SLIT2
19cellular response to vascular endothelial growth factor stimulusGO:00359249.8FLT1, VEGFA
20negative regulation of blood vessel endothelial cell migrationGO:00435379.8FGF2, HRG, THBS1
21positive regulation of phosphatidylinositol 3-kinase signalingGO:00140689.8FLT1, KDR, TEK
22positive regulation of protein phosphorylationGO:00019349.7FGF2, TEK, VEGFA
23protein autophosphorylationGO:00467779.7FLT1, KDR, TEK
24negative regulation of inflammatory responseGO:00507289.7SERPINF1, SLIT2, TEK
25positive regulation of protein kinase B signalingGO:00518979.7FGF2, TEK, THBS1
26platelet degranulationGO:00025769.7HRG, PLG, VEGFA
27positive regulation of focal adhesion assemblyGO:00518949.6HRG, KDR, TEK
28peptidyl-tyrosine phosphorylationGO:00181089.5FGF2, FLT1, KDR, TEK
29negative regulation of endothelial cell migrationGO:00105969.5SERPINF1, SLIT2, THBS1
30response to hypoxiaGO:00016669.4CXCL12, FLT1, THBS1
31blood coagulationGO:00075969.3PLG, TEK, THBS1, VEGFA
32negative regulation of endopeptidase activityGO:00109519.3HRG, SERPINF1, TIMP2
33nervous system developmentGO:00073999.2FGF2, ROBO1, VEGFA
34negative regulation of angiogenesisGO:00165259.2HRG, SERPINF1, TEK, THBS1
35negative regulation of apoptotic processGO:00430669.1KDR, TEK, THBS1, VEGFA
36positive regulation of angiogenesisGO:00457669.1FGF2, FLT1, KDR, TEK, VEGFA
37extracellular matrix organizationGO:00301989.0FGF2, KDR, THBS1, TIMP2
38angiogenesisGO:00015258.2FGF2, HRG, KDR, TEK, VEGFA

Molecular functions related to Corneal Neovascularization according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein tyrosine kinase activityGO:00047139.3FLT1, KDR, TEK

Sources for Corneal Neovascularization

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet